FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment.
Fukumoto S.
J Mol Endocrinol. 2021 Feb;66(2):R57-R65. doi: 10.1530/JME-20-0089.
FGF23 and Hypophosphatemic Rickets/Osteomalacia.
Takashi Y, Kawanami D, Fukumoto S.
Curr Osteoporos Rep. 2021 Dec;19(6):669-675. doi: 10.1007/s11914-021-00709-4. Epub 2021 Nov 10.
Revisiting hypophosphatemic rickets/osteomalacia.
Bandgar T, Shah N.
Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101859. doi: 10.1016/j.beem.2024.101859. Epub 2024 Jan 6.
Approach to Hypophosphatemic Rickets.
Ackah SA, Imel EA.
J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488.
Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia.
Ito N, Hidaka N, Kato H.
Endocrinol Metab (Seoul). 2024 Apr;39(2):255-261. doi: 10.3803/EnM.2023.1908. Epub 2024 Mar 11.
The pathophysiology of hypophosphatemia.
Ito N, Hidaka N, Kato H.
Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30.
Hypophosphatemic osteomalacia, a side effect of iron carboxymaltose administration.
Madero Velázquez L, Muñoz Pérez R, Rodríguez A, Bernal L, Orts B, Sempere L, Gutiérrez Casbas A.
Rev Esp Enferm Dig. 2022 Jun;114(6):358. doi: 10.17235/reed.2022.8621/2022.
Sporadic hypophosphatemic osteomalacia combined with psoriasis: A rare case report and a brief review of the literature.
Li Y, Chen X, Wang B, Liu X, Hou S.
Int J Rheum Dis. 2023 May;26(5):968-972. doi: 10.1111/1756-185X.14562. Epub 2023 Jan 10.
New treatments for rare bone diseases: hypophosphatemic rickets/osteomalacia.
Marques JVO, Moreira CA, Borba VZC.
Arch Endocrinol Metab. 2022 Nov 11;66(5):658-665. doi: 10.20945/2359-3997000000555.
Hypophosphatemic rickets and osteomalacia.
de Menezes Filho H, de Castro LC, Damiani D.
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):802-13. doi: 10.1590/s0004-27302006000400025.
